Medical Tourism Sector in Malaysia Driven by High Patient Visits for Chronic Disorder Treatment, Fact.MR Analysis
Medical Tourism Sector in Malaysia Driven by High Patient Visits for Chronic Disorder Treatment, Fact.MR Analysis
The number of foreign patients visiting Malaysia for treatment procedures related to cardiovascular, orthopedic, and oncology is high. As per this updated industry analysis by Fact.MR, a market research and competitive intelligence provider, revenue from medical tourism in Malaysia is projected to jump from US$ 1.92 billion in 2024 to US$ 7.54 billion by the end of 2034.
Chronic diseases are main focus point for healthcare providers in Malaysia. The presence of advanced healthcare infrastructure, affordable medical facilities, and low language barrier are some of the factors boosting the market growth in Malaysia. The country has the presence of latest medical technologies and equipment coupled with skilled medical experts. The increasing investment by Malaysia government in healthcare excellence is set to boost the medical tourism in the country.
Ongoing developments in telemedicine, information and communication technology, and telehealth in Malaysia are driving attention of patients worldwide. The country’s medical sector is also advancing specifically in oncology. Most patients visiting Malaysia are seeking cancer treatment. The treatment affordability and presence of cutting-edge technologies are attracting cancer patients for treatment.
Healthcare providers are also focusing on advancing their post treatment facilities. The availability of proper medicine and post-treatment in patient’s country as well as regular telephonic follow-up is set to increase popularity of Malaysia’s medical system.
For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=7264
Key Takeaways from the Market Study:
“Supportive government policies for medical tourism key factor driving market growth in Malaysia,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Malaysia Medical Tourism Market
KPJ Healthcare Berhad; LohGuanLye Specialists Centre; Mahkota Medical Centre; Dentalpro Group; Sunway Medical Centre; Prince Court Medical Centre; Island Hospital
Competitive Analysis
Key players in the Malaysia market are investing heavily in R&D to improve their product and service quality. Contractual agreements, mergers, acquisitions, innovations, and collaborations with other organizations are some of the tactics adopted by them.
Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=7264
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global Malaysia medical tourism market, presenting historical demand data (2018 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights on the market based on procedure type (cardiovascular treatment, oncology, fertility treatment (IVF), orthopedic treatment, dental treatment, ophthalmology, aesthetics/cosmetic surgeries, neurology, regenerative therapy (stem cells), medical check-ups (health screening), others), service (wellness services, therapeutic services), and customer orientation (men, women, children).
Check out More Related Studies Published by Fact.MR:
The urinary tract infection treatment market is projected to grow at a 2.1% CAGR, reaching US$ 12.9 billion by 2031 from US$ 10.5 billion in 2021.
The biomedical textiles market is expected to reach US$ 17 billion by 2032, expanding at a 5% CAGR.
The drainage bottles market, valued at US$ 473.3 million in 2021, is projected to grow at an 8.5% CAGR through 2032.
The bioabsorbable stents market is set to expand at a 9.6% CAGR, reaching nearly US$ 1 billion by 2032 from US$ 372 million in 2021.
Next-generation patient monitoring devices are forecasted to grow at an 8.9% CAGR, increasing from US$ 4.38 billion in 2022 to US$ 10.27 billion by 2032.
The endometrial ablation devices market, currently valued at US$ 1.02 billion, is expected to reach US$ 1.25 billion by 2027, growing at a 4% CAGR.
The addiction treatment market is poised for a 6.7% CAGR expansion, generating an opportunity worth US$ 50 million over the next decade.
The microbiome therapeutics market, valued at US$ 112.2 million in 2022, is expected to surge at a 32% CAGR, reaching US$ 1.8 billion by 2032.
Explore more articles in the Research Reports category
